Clinical Trials Sponsored by Kolon Life Science

Total 835 results

Power Life Sciences Inc.

Not yet recruiting

A Close Examination of Patient Experiences in Glioblastoma Multiforme Clinical Research

Glioblastoma Multiforme

United States
Power Life Sciences Inc.

Not yet recruiting

Exploring Clinical Study Experiences of People With Depression

Depression

United States
Power Life Sciences Inc.

Not yet recruiting

Pinpointing the Factors Affecting Clinical Study Experiences of Pulmonary Fibrosis Patients

Pulmonary Fibrosis

United States
Power Life Sciences Inc.

Not yet recruiting

A Close Examination of Patient Experiences in Bipolar Disorder Clinical Trials

Bipolar Disorder

United States
Power Life Sciences Inc.

Recruiting

Discovering Factors in the Clinical Study Journey of Patients With OCD

Obsessive-Compulsive Disorder | OCD

United States
Power Life Sciences Inc.

Not yet recruiting

An In Depth Study Evaluating The Experiences of Patients In Schizophrenia Research

Schizophrenia
Power Life Sciences Inc.

Not yet recruiting

Assessing Medical Trial Experiences of Hairy Cell Leukemia Patients

Hairy Cell Leukemia
Power Life Sciences Inc.

Not yet recruiting

In Depth Observational Clinical Trial Of Retinitis Pigmentosa Patients

Retinitis Pigmentosa
Power Life Sciences Inc.

Not yet recruiting

Discovering Patterns in Experiences of Patients in Esophageal Cancer Clinical Research

Esophageal Cancer
Power Life Sciences Inc.

Not yet recruiting

Evaluating Trends in Anaplastic Thyroid Cancer Patients' Clinical Study Experiences

Anaplastic Thyroid Cancer
Power Life Sciences Inc.

Not yet recruiting

Investigating Medical Research Trends in Osteoarthritis Clinical Trials

Osteoarthritis
Power Life Sciences Inc.

Not yet recruiting

Examination of Trends in Non-Small Cell Lung Cancer Patients' Medical Study Experiences

Non-Small Cell Lung Cancer
Power Life Sciences Inc.

Not yet recruiting

Analyzing the Factors in Ulcerative Colitis Patients' Clinical Trial Experiences

Ulcerative Colitis
Power Life Sciences Inc.

Not yet recruiting

Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma Patients

Glioblastoma
Power Life Sciences Inc.

Not yet recruiting

Investigating the Experiences of Individuals With Gastric Cancer Participating in Clinical Trials

Gastric Cancer
Power Life Sciences Inc.

Not yet recruiting

Evaluation of the Patient's Experience in Medical Studies for Cholangiocarcinoma

Cholangiocarcinoma
Power Life Sciences Inc.

Not yet recruiting

Examining the Experiences of Brain Injury Patients in Medical Trials

Brain Injuries
Kezar Life Sciences, Inc.

Recruiting

A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)

Autoimmune Hepatitis

United States
Power Life Sciences Inc.

Not yet recruiting

Evaluating Clinical Trial Experiences of Individuals With Congestive Heart Failure

Congestive Heart Failure
CANbridge Life Sciences Ltd.

Recruiting

Phase 2 Study of CAN008 in Subjects With GBM

Newly-diagnosed Glioblastoma

China
Power Life Sciences Inc.

Not yet recruiting

Investigating The Experiences of Patients In Immunotherapy Clinical Trials

Cancer | Immunotherapy
Power Life Sciences Inc.

Not yet recruiting

Analyzing Clinical Trial Experiences of Prostate Cancer Patients

Prostate Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Medical Trial: Appraising Medical Trial Experiences of Rheumatoid Arthritis Patients

Rheumatoid Arthritis

United States
Suven Life Sciences Limited

Recruiting

Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type

Agitation | Alzheimer's Type Dementia

Croatia, United States, Poland, Serbia
Sellas Life Sciences Group

Active, not recruiting

Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2 (REGAL)

Acute Myeloid Leukemia

United States, Spain, France, Taiwan, India, Hungary, Poland, Germany, Serbia, Greece
TriSalus Life Sciences, Inc.

Active, not recruiting

Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma

Metastatic Uveal Melanoma in the Liver

United States
Verily Life Sciences LLC

Withdrawn

Verily Watch Cardio (AF and ECG) Study

Atrial Fibrillation

United States
Wave Life Sciences Ltd.

Terminated

Open-label Extension (OLE) Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) and/or Frontotemporal Dementia (FTD)

ALS | FTD

Netherlands, United Kingdom
Suven Life Sciences Limited

Completed

SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study

Alzheimer's Disease

United States
Sellas Life Sciences Group

Available

Expanded Access Program (EAP) for Galinpepimut-S (GPS) in Patients Diagnosed With AML or MDS

Acute Myeloid Leukemia | Myelodysplastic Syndromes
Tiziana Life Sciences LTD

Withdrawn

In-patient COVID-19 Study of Intranasal Foralumab

Covid19 | COVID-19 Respiratory Infection | COVID-19 Lower Respiratory Infection
Wave Life Sciences Ltd.

Terminated

Safety and Tolerability of WVE-120101 in Patients With Huntington's Disease (PRECISION-HD1)

Huntington's Disease

Denmark, Canada, Australia, United Kingdom, France, Germany, Poland
Wave Life Sciences Ltd.

Terminated

Open-label Extension Study to Evaluate the Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease

Huntington Disease

Denmark, Australia, Canada, France, United Kingdom, Germany, Poland
Verily Life Sciences LLC

Active, not recruiting

Predictors of Severe COVID-19 Outcomes (PRESCO)

COVID-19 | Acute Respiratory Distress Syndrome

United States
Anavex Life Sciences Corp.

Completed

An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

Australia
Kezar Life Sciences, Inc.

Withdrawn

A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP (MARINA)

Immune Thrombocytopenia | Autoimmune Hemolytic Anemia

Poland, United States, Australia, Italy, Russian Federation
Tiziana Life Sciences LTD

Withdrawn

Assessment of the Safety of Foralumab, an Oral Anti-CD3 Antibody, in Patients With NASH and T2DM

NAFLD | NASH - Nonalcoholic Steatohepatitis | T2DM (Type 2 Diabetes Mellitus)
Wave Life Sciences Ltd.

Completed

Safety and Tolerability of WVE-210201 in Patients With Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy

Belgium, United Kingdom, France, United States, Italy, Canada, Netherlands
Anavex Life Sciences Corp.

Completed

Phase 2a Dose Finding, PK/PD and 12 Month Exploratory Efficacy Study of ANAVEX2-73 in Patients With Alzheimer's Disease (ANAVEX)

Alzheimer's Disease

Australia
Precision Life Sciences Group

Completed

A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma

Glioblastoma Multiforme

United States
Suven Life Sciences Limited

Completed

A Study to Investigate the Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-D4010 in Healthy Subjects

Cognitive Disorder

United States
Bioniche Life Sciences Inc.

Completed

Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer

Bladder Neoplasms

Canada, United States
Power Life Sciences Inc.

Not yet recruiting

Understanding Participation Habits Among Plaque Psoriasis Patients

Plaque Psoriasis

United States
Power Life Sciences Inc.

Not yet recruiting

Understanding Patient Engagement Trends in TBI Clinical Research

TBI

United States
Power Life Sciences Inc.

Not yet recruiting

An Observational Exploration of Clinical Trials Targeting Traumatic Brain Injury

Traumatic Brain Injury

United States
Power Life Sciences Inc.

Not yet recruiting

Understanding of Participation Trends Within Generalized Anxiety Disorder Patients Involved in Clinical Trials

Generalized Anxiety Disorder

United States
Power Life Sciences Inc.

Not yet recruiting

A Journey Into Participation Patterns Among Patients With Hidradenitis Suppurativa

Hidradenitis Suppurativa

United States
ReAlta Life Sciences, Inc.

Recruiting

Safety, PK and PD Relationships of RLS-0071 in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Acute Exacerbation of Chronic Obstructive Pulmonary Disease

United States
Power Life Sciences Inc.

Not yet recruiting

Understanding Patient Engagement Trends in Anxiety Disorder Clinical Research

Anxiety Disorder

United States
Suven Life Sciences Limited

Recruiting

Study Evaluating Safety and Efficacy of Ropanicant in MDD Patients

Major Depressive Disorder

United States

Clinical Trials Sponsored by Kolon Life Science

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations